Human amniotic epithelial stem cell is a cell therapy candidate for preventing acute graft-versus-host disease.
Yang PJ, Zhao XY, Kou YH, Liu J, Ren XY, Zhang YY, Wang ZD, Ge Z, Yuan WX, Qiu C, Tan B, Liu Q, Shi YN, Jiang YQ, Qiu C, Guo LH, Li JY, Huang XJ, Yu LY.
Yang PJ, et al. Among authors: kou yh.
Acta Pharmacol Sin. 2024 May 27. doi: 10.1038/s41401-024-01283-y. Online ahead of print.
Acta Pharmacol Sin. 2024.
PMID: 38802569